Sitemap
November 13, 2023 Articles
Filter by Available Specialty
- Benralizumab lowers COPD exacerbations in asthma, COPD at 1 year
- Bone density decreases when stopping, never using menopausal hormone therapy
- Cancer immunotherapy diminishes peak COVID-19 vaccine antibody response
- Caregivers of toddlers ‘ready to go’ for peanut oral immunotherapy, yet meet many hurdles
- COVID-19 linked to decrease in obstetric intervention, increase in perinatal mortality
- COVID-19 rebounds in one in five Paxlovid users
- Discussing DED treatment cost can help build trust, lead to more same-day procedures
- Durvalumab regimen extends PFS in certain patients with liver cancer
- Extended oral tranexamic acid may improve outcomes after TKA
- FDA agrees to design of phase 3 trial for choroidal melanoma treatment
- Few patients with kidney cancer who meet evaluation criteria receive genetic counseling
- Five stories for the start of flu season
- Gender gap in life expectancy widens amid COVID-19, drug overdose crisis
- Guiding an ‘aesthetically oriented public’ away from loosely regulated medical spas
- Hooked on Primary Care with Monique Gary, DO
- How behavioral finance impacts physicians’ decision making
- Hydroxychloroquine use predicts lower risk for fatty liver disease in rheumatoid arthritis
- Intensive BP lowering confers mortality benefit in Asian cohort
- Interstitial lung disease can develop ‘in any stage’ of systemic sclerosis
- Intervention boosts discussion of out-of-pocket HF drug costs between patients, doctors
- Lepodisiran substantially lowers Lp(a) in early trial
- Live from AAO Eyecelerator 2023
- MASH now top indication for liver transplantation in those with hepatocellular carcinoma
- MASH resolution without worsening fibrosis boosts 15-year survival after bariatric surgery
- Neurofilament light chain predicted confirmed disability worsening at 1 to 2 years in MS
- Nonwhite individuals appear underrepresented in food allergy clinical trials
- Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis
- Ora, BlindCAN Film Festival launch Blind Canvas Project, create art inspired by blindness
- Physical and mental health measures worse for adults with HF vs. lung, colorectal cancers
- Poll: Americans feel better after small acts of kindness
- Povorcitinib outperforms placebo as treatment for hidradenitis suppurativa
- Pregnant patients with low anti-Ro titers have ‘little to no’ risk for fetal heart block
- Prioritize personal health, financial independence on the path to retirement
- Provider training alone may not be enough to improve advanced care planning
- Q&A: Benefits of pulmonary point-of-care ultrasonography
- Q&A: Oral health screening in children
- Regular marijuana use linked to risk for HF, major adverse heart, brain events
- Researchers estimate global food allergy prevalence using standardized methodology
- Screening for peripartum cardiomyopathy using AI-enhanced digital stethoscope shows promise
- Several comorbidities found to be independent risk factors for late PJI after TKA
- Smartphone-based speech analysis app may predict worsening heart failure
- Survey finds neurologists seek to minimize side effects of treatment in Parkinson’s
- Survey: Preventing serious reactions comes first in treating children with food allergy
- Testosterone treatment boosts hemoglobin levels for older men with anemia
- TMP-SMX reduces serious infections ‘by about half’ in patients with GPA using rituximab
- Top in cardiology: New options for statin intolerance; heart benefits of Wegovy
- Transarterial chemoembolization plus vitamin K enhances anticancer effects on HCC
- VIDEO: Biggest treatment challenges for patients with hyperphosphatemia
- VIDEO: Deepak L. Bhatt, MD, MPH, highlights new data on semaglutide, tirzepatide at AHA
- VIDEO: Drugs in the pipeline for hyperphosphatemia management
- VIDEO: Latest treatment advancements in hyperphosphatemia
- VIDEO: Progressive pediatric myopia treatment at the tail end of phase 3 clinical trial
- VIDEO: Unmet needs of patients with hyperphosphatemia
- Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma